Answer these 5 quick questions
Question 1 of 5
Select Answer
Thanks for taking the quiz!
Get more info about the iTind procedure
Compare the iTind procedure versus other methods of managing BPH symptoms.
Hover over each square below to learn more
BPH
Medications
Low adherence to daily BPH medication often means patients stop using it within
12 months5
Plus,
many experience undesirable sexual side effects6
The iTind
Procedure
(~5%)
Post-procedure catheterization is rare7
No incidence of de novo sexual dysfunction in studies8
Permanent
Implants
32%
catheterization rate9
No incidence of de novo sexual dysfunction in studies10
Steam
Treatments
90%
catheterization rate7
No incidence of de novo sexual dysfunction in studies11
TURP
46%
incidence of retrograde ejaculation12, 13
6%
incidence of erectile dysfunction12, 13
- 5 Cindolo L, Pirozzi L, Fanizza C, Romero M, Tubaro A, Autorino R, De Nunzio C, Schips L. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol. 2015 Sep;68(3):418-25. doi: 10.1016/j.eururo.2014.11.006. Epub 2014 Nov 20. PMID: 25465970.
- 6 Malde S, Lam W, Adwin Z, Hashim H. Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review. BJUI Compass. 2021 Feb 3;2(4):238-259. doi: 10.1002/bco2.74. PMID: 35475299; PMCID: PMC8988658.
- 7 Amparore et al., 2023 and Chughtai et al., 2021
- 8 De Nunzio et al., 2021 and Chughtai et al., 2021 and Amparore et al., 2023
- 9 Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190(6):2161-2167. doi:10.1016/j.juro.2013.05.116
- 10 Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Herron S, Rashid P, Rukstalis DB. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017 Jun;24(3):8802-8813. PMID: 28646935.
- 11 McVary KT, Gange SN, Gittelman MC, et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2016;195(5):1529-1538. doi:10.1016/j.juro.2015.10.181
- 12 Porto JG, Bhatia AM, Bhat A, Suarez Arbelaez MC, Blachman-Braun R, Shah K, Malpani A, Lopategui D, Herrmann TRW, Marcovich R, Shah HN. Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century. World J Urol. 2025 Jan 24;43(1):85. doi: 10.1007/s00345-024-05439-7. PMID: 39856398; PMCID: PMC11761131.
- 13 Porto JG, Bhatia AM, Bhat A, Suarez Arbelaez MC, Blachman-Braun R, Shah K, Malpani A, Lopategui D, Herrmann TRW, Marcovich R, Shah HN. Evaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials. World J Urol. 2024 Nov 15;42(1):639. doi: 10.1007/s00345-024-05332-3. PMID: 39547977; PMCID: PMC11568034.
